These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 18579209

  • 1. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
    Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB, Thorne JE.
    Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP.
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
    Sobrin L, Christen W, Foster CS.
    Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
    [Abstract] [Full Text] [Related]

  • 4. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
    Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan JD, Rao MM, Ebert CD, Nguyen HH, Kim E, Porco TC, Acharya NR, FAST Research Group.
    JAMA; 2019 Sep 10; 322(10):936-945. PubMed ID: 31503307
    [Abstract] [Full Text] [Related]

  • 5. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.
    Gangaputra SS, Newcomb CW, Joffe MM, Dreger K, Begum H, Artornsombudh P, Pujari SS, Daniel E, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Kempen JH, SITE Cohort Research Group.
    Am J Ophthalmol; 2019 Dec 10; 208():68-75. PubMed ID: 31344346
    [Abstract] [Full Text] [Related]

  • 6. Azathioprine for ocular inflammatory diseases.
    Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB.
    Am J Ophthalmol; 2009 Oct 10; 148(4):500-509.e2. PubMed ID: 19570522
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil for ocular inflammation.
    Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Foster CS, Jabs DA, Kempen JH.
    Am J Ophthalmol; 2010 Mar 10; 149(3):423-32.e1-2. PubMed ID: 20042178
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
    Cuchacovich M, Solanes F, Perez C, Verdaguer JI, Verdaguer J, Castiglione E, Carpentier C, Traipe L, Villarroel F.
    J Ocul Pharmacol Ther; 2016 Mar 10; 32(1):55-61. PubMed ID: 26562247
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep 10; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 10. Methotrexate for ocular inflammatory diseases.
    Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH, Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study.
    Ophthalmology; 2009 Nov 10; 116(11):2188-98.e1. PubMed ID: 19748676
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil for the treatment of uveitis.
    Teoh SC, Hogan AC, Dick AD, Lee RW.
    Am J Ophthalmol; 2008 Nov 10; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
    [Abstract] [Full Text] [Related]

  • 12. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
    Rathinam SR, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, Lee SM, Enanoria WT, Porco TC, Browne EN, Weinrib R, Acharya NR.
    Ophthalmology; 2014 Oct 10; 121(10):1863-70. PubMed ID: 24917273
    [Abstract] [Full Text] [Related]

  • 13. The first investigation on differences in the effectiveness of mycophenolate mofetil and azathioprine antimetabolites determined in Polish patients treated for non-infectious uveitis.
    Waszczyk-Łączak M, Łazicka-Gałecka M, Chomicz L, Mucha K, Pączek L, Szaflik JP.
    Ann Agric Environ Med; 2020 Dec 22; 27(4):644-649. PubMed ID: 33356073
    [Abstract] [Full Text] [Related]

  • 14. Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease.
    Baker KB, Spurrier NJ, Watkins AS, Smith JR, Rosenbaum JT.
    Br J Ophthalmol; 2006 Dec 22; 90(12):1481-5. PubMed ID: 16914474
    [Abstract] [Full Text] [Related]

  • 15. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Bonsmann G, Luger TA.
    Arch Dermatol; 2007 Dec 22; 143(12):1536-42. PubMed ID: 18087004
    [Abstract] [Full Text] [Related]

  • 16. Treatment of chronic non-infectious uveitis and scleritis.
    Rossi DC, Ribi C, Guex-Crosier Y.
    Swiss Med Wkly; 2019 Feb 25; 149():w20025. PubMed ID: 30852832
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
    Tsui E, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan J, Ebert CD, Kim E, Madow B, Porco TC, Acharya NR, FAST Research Group.
    Ophthalmology; 2022 Jun 25; 129(6):661-667. PubMed ID: 35143800
    [Abstract] [Full Text] [Related]

  • 18. A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis.
    Browne EN, Rathinam SR, Kanakath A, Thundikandy R, Babu M, Lietman TM, Acharya NR.
    Ophthalmic Epidemiol; 2017 Feb 25; 24(1):63-70. PubMed ID: 27982726
    [Abstract] [Full Text] [Related]

  • 19. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
    Wieringa WG, Wieringa JE, ten Dam-van Loon NH, Los LI.
    Ophthalmology; 2013 Feb 25; 120(2):379-86. PubMed ID: 23177360
    [Abstract] [Full Text] [Related]

  • 20. Outcomes in Patients With Vogt-Koyanagi-Harada Disease From the First-Line Antimetabolites for Steroid-Sparing Treatment Uveitis Trial.
    Acharya NR, Rathinam SR, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Gonzales JA, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Arellanes-Garcia L, Coyne A, Porco TC, Shantha JG, FAST Research Group.
    Am J Ophthalmol; 2024 Nov 25; 267():100-111. PubMed ID: 38909740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.